Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $12.7 million.

  • SBC Medical Group Holdings' Cost of Revenue rose 2941.31% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.2 million, marking a year-over-year decrease of 2000.96%. This contributed to the annual value of $49.4 million for FY2024, which is 1222.18% down from last year.
  • SBC Medical Group Holdings' Cost of Revenue amounted to $12.7 million in Q3 2025, which was up 2941.31% from $13.3 million recorded in Q2 2025.
  • SBC Medical Group Holdings' Cost of Revenue's 5-year high stood at $19.0 million during Q4 2023, with a 5-year trough of $9.6 million in Q1 2025.
  • Its 3-year average for Cost of Revenue is $13.1 million, with a median of $13.3 million in 2025.
  • As far as peak fluctuations go, SBC Medical Group Holdings' Cost of Revenue tumbled by 4443.16% in 2024, and later soared by 2941.31% in 2025.
  • Over the past 3 years, SBC Medical Group Holdings' Cost of Revenue (Quarter) stood at $19.0 million in 2023, then tumbled by 44.43% to $10.5 million in 2024, then grew by 20.8% to $12.7 million in 2025.
  • Its Cost of Revenue was $12.7 million in Q3 2025, compared to $13.3 million in Q2 2025 and $9.6 million in Q1 2025.